Biltmore Capital Advisors’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q4
$3.71M Buy
21,712
+2,479
+13% +$406K 0.62% 33
2021
Q3
$3.11M Buy
19,233
+52
+0.3% +$8.87K 0.57% 35
2021
Q2
$3.16M Buy
19,181
+45
+0.2% +$7.45K 0.58% 35
2021
Q1
$3.15M Buy
19,136
+2,254
+13% +$365K 0.68% 32
2020
Q4
$2.66M Buy
16,882
+2,386
+16% +$352K 0.73% 29
2020
Q3
$2.16M Sell
14,496
-337,003
-96% -$49.9M 0.63% 25
2020
Q2
$49.4M Buy
351,499
+770
+0.2% +$112K 13.65% 2
2020
Q1
$46M Buy
350,729
+111,276
+46% +$15.8M 16.39% 2
2019
Q4
$34.9M Sell
239,453
-4,075
-2% -$553K 10.37% 2
2019
Q3
$31.5M Buy
243,528
+34
+0% +$4.48K 8.31% 2
2019
Q2
$33.9M Buy
243,494
+231
+0.1% +$32K 9.9% 2
2019
Q1
$3.4M Buy
+243,263
New +$32.6M 1.1% 23

Other funds holding JNJ

Biltmore Capital Advisors's JNJ Position: Q4 2021 in Review

Biltmore Capital Advisors increased its Johnson & Johnson (JNJ) stake by 13% in Q4 2021, buying an estimated $406K and bringing the position to 21,712 shares worth $3.71M. The position accounts for 0.62% of the portfolio, ranked #33.

Biltmore Capital Advisors first reported a position in JNJ in Q1 2019 and has held it in 12 quarters since. The position peaked at $49.4M in Q2 2020. 3,644 funds tracked by Wall St. Rank hold JNJ as of Q4 2021.

  • Biltmore Capital Advisors held 21,712 shares of Johnson & Johnson worth $3.71M as of Q4 2021.
  • Biltmore Capital Advisors bought 2,479 Johnson & Johnson shares in Q4 2021, an estimated $406K.
  • Johnson & Johnson made up 0.62% of Biltmore Capital Advisors's portfolio in Q4 2021, its #33 holding.
  • Biltmore Capital Advisors first reported a position in Johnson & Johnson in Q1 2019 and has held it in 12 quarters since.
  • Biltmore Capital Advisors's Johnson & Johnson position peaked at $49.4M in Q2 2020.
  • 3,644 funds tracked by Wall St. Rank held Johnson & Johnson as of Q4 2021.

Based on Biltmore Capital Advisors's 13F filing for Q4 2021, filed 8 Feb 2022.